Umasankar Kulandaivelu

Development of selective and reversible pyrazoline based MAO-A inhibitors: Synthesis, biological evaluation and docking studies

Muthukumar Karuppasamy, Manoj Kumar Mahapatra, Samiye Yabanoğlu et al. · Bioorganic & Medicinal Chemistry · 2010 · 58 citations · Full text

Medicinal Chemistry, Biochemistry, Docking Studies +11

Synthesis, Antimicrobial and Anticancer Activity of New Thiosemicarbazone Derivatives

Umasankar Kulandaivelu, Valisakka Gari Padmini, Kyatham Suneetha et al. · Archiv der Pharmazie · 2010 · 55 citations · Full text

Synthesis, Antimicrobial Evaluation, and Docking Studies of Novel 4‐Substituted Quinazoline Derivatives as DNA‐Gyrase Inhibitors

Shireesha Boyapati, Umasankar Kulandaivelu, Srinivas Sangu et al. · Archiv der Pharmazie · 2010 · 37 citations

Molecular docking studies and in vitro screening of new dihydropyridine derivatives as human MRP1 inhibitors

Kalam Sirisha, Maddela Chandra Shekhar, Umasankar Kulandaivelu et al. · Bioorganic & Medicinal Chemistry · 2011 · 30 citations · Full text

Molecular Docking, Molecular Docking Studies, Medicinal Chemistry +12

Synthesis, in vitro antimycobacterial evaluation and docking studies of some new 5,6,7,8-tetrahydropyrido[4′,3′:4,5]thieno[2,3-d]pyrimidin-4(3H)-one schiff bases

Narender Malothu, Bhandaru Jaswanth S., Umasankar Kulandaivelu et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 21 citations · Full text